WOBURN, Mass.– Medical device developer Qlibrium has relocated from a laboratory at University of Massachusetts Lowell’s Massachusetts Medical Device Development Center to 16 Tower Office Park, a Cummings Properties-managed building in Woburn’s growing science and technology community.
The 4,700-square-foot facility will house the firm’s offices as well as its research and development functions.
Formerly known as Cam Med Inc., Qlibrium was founded in 2014 with the aim of developing an improved platform for injectable drug delivery. Its QLib OBDS (On-Body Delivery System) platform is a wearable ultra-thin and lightweight pump equipped to deliver liquid medications via subcutaneous injection.
Qlibrium was selected as a MassChallenge Gold Winner in 2014 and one of MedTech Innovator’s Top 100 Companies in 2017.
“The space is well-suited for us as we enter our next stage of growth and is situated within 20 minutes’ drive of many of our current and potential strategic partners,” said Larry Alberts, CEO and co-founder of Qlibrium.
Senior Leasing Director Rob Yacobian of Cummings Properties worked with T3 Advisors partner Austin Barrett on the lease.
“Having come from an incubator environment, Qlibrium was focused on locating its new facility in a medtech hub with ready access to a strong science-oriented talent pool and area amenities,” said Yacobian. “We were pleased to accommodate the firm’s expansion in Woburn’s thriving biotech cluster.”
Among Qlibrium’s new neighbors are biotech firms Amgen, Azurity Pharmaceuticals, Covaris, HD Lifesciences, Medtronic, Minovia Therapeutics, and Verdox.
